A detailed history of Telemetry Investments, L.L.C. transactions in Brickell Biotech, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 65,000 shares of BBI stock, worth $114,400. This represents 0.15% of its overall portfolio holdings.

Number of Shares
65,000
Previous 66,000 1.52%
Holding current value
$114,400
Previous $118,000 19.49%
% of portfolio
0.15%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.71 - $2.08 $1,710 - $2,080
-1,000 Reduced 1.52%
65,000 $95,000
Q3 2022

Nov 17, 2022

BUY
$1.72 - $4.41 $113,520 - $291,060
66,000 New
66,000 $118,000

Others Institutions Holding BBI

# of Institutions
1
Shares Held
65K
Call Options Held
0
Put Options Held
0

About Brickell Biotech, Inc.


  • Ticker BBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,873,960
  • Market Cap $6.75M
  • Description
  • Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary ...
More about BBI
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.